PR
Alterity Therapeutics Limited
PRNAF · OTC
$0.06 +0.00% (+$0.00)
Market Cap $17.3M
P/E Ratio -
Div. Yield -
ROE 141.08%
Piotroski F-Score Weak
3/9Valuation
85 /100
Cheap P/S 2.30x
P/B 0.41x
P/E N/A
Growth
100 /100
Growing Book val. growth 29.32%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 95.89%
FCF margin 265.48%
Net margin 381.67%
Quality
2 /100
Poor ROIC 72.18%
Asset turnover 0.16x
ROE 141.08%
Debt
94 /100
Low Debt/Equity 0.00x
Net debt/EBITDA 1.08x
Current ratio 12.98x
Stability
49 /100
Moderate Beta -0.04x
Profitable years 0
EPS volatility 27.78%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre PRNAF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
David A. Stamler
Employees
11
Headquarters
Melbourne
Evenimente viitoare
04 MAR.
Earnings
Upcoming earnings report